David is a Senior Advisor on the Life Sciences team and has extensive experience in the capital markets.
David joined Frazier in March 2020 and brings considerable capital markets experience to the Life Sciences team. He currently serves as Chief Financial Officer of Frazier Lifesciences Acquisition Corporation (NASDAQ: FLAC).
David is a board director of Amherst Pierpont Securities and a board observer and advisor to CircleUp. He was previously an Operating Partner at General Atlantic, providing capital markets expertise to portfolio companies, and a member of the Portfolio Committee. Prior to General Atlantic, David was Co-Head of Equity Capital Markets at J.P. Morgan, where he led the firm’s major advisory and capital-raising transactions and worked with the U.S. Treasury and other regulatory agencies on crisis-related issues. He also served as Chairman of the Commitments Committee at J.P. Morgan. Prior to this, David spent 22 years at Morgan Stanley where he served as Co-Head of U.S. Equity Capital Markets, Managing Director, and Chairman of the Equity Commitment Committee. Earlier in his career, he held several other senior management positions in Morgan Stanley’s Debt Capital Markets, Leveraged Finance, and Mergers & Acquisitions divisions.
David received his B.A. from Duke University and his M.B.A. from Stanford Graduate School of Business.
Duke University (B.A.)
Stanford Graduate School of Business (M.B.A.)